336 related articles for article (PubMed ID: 27819130)
1. Current status and future prospects of mesenchymal stem cell therapy for liver fibrosis.
Guo Y; Chen B; Chen LJ; Zhang CF; Xiang C
J Zhejiang Univ Sci B; 2016 Nov.; 17(11):831-841. PubMed ID: 27819130
[TBL] [Abstract][Full Text] [Related]
2. [Umbilical cord mesenchymal stem cells and their association with liver fibrosis].
Tuo L; Zeng WZ; Xue HL; Wu XL
Zhonghua Gan Zang Bing Za Zhi; 2017 Jan; 25(1):65-68. PubMed ID: 28297787
[TBL] [Abstract][Full Text] [Related]
3. Tonsil-derived mesenchymal stem cells ameliorate CCl4-induced liver fibrosis in mice via autophagy activation.
Park M; Kim YH; Woo SY; Lee HJ; Yu Y; Kim HS; Park YS; Jo I; Park JW; Jung SC; Lee H; Jeong B; Ryu KH
Sci Rep; 2015 Feb; 5():8616. PubMed ID: 25722117
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal stem cell therapy for liver fibrosis.
Eom YW; Shim KY; Baik SK
Korean J Intern Med; 2015 Sep; 30(5):580-9. PubMed ID: 26354051
[TBL] [Abstract][Full Text] [Related]
5. Strategies to improve the efficiency of mesenchymal stem cell transplantation for reversal of liver fibrosis.
Hu C; Zhao L; Duan J; Li L
J Cell Mol Med; 2019 Mar; 23(3):1657-1670. PubMed ID: 30635966
[TBL] [Abstract][Full Text] [Related]
6. Enhanced hepatic differentiation of mesenchymal stem cells after pretreatment with injured liver tissue.
Mohsin S; Shams S; Ali Nasir G; Khan M; Javaid Awan S; Khan SN; Riazuddin S
Differentiation; 2011 Jan; 81(1):42-8. PubMed ID: 20943307
[TBL] [Abstract][Full Text] [Related]
7. Advances in mesenchymal stem cells combined with traditional Chinese medicine therapy for liver fibrosis.
Dong S; Su SB
J Integr Med; 2014 May; 12(3):147-55. PubMed ID: 24861835
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stem cells and their secreted molecules predominantly ameliorate fulminant hepatic failure and chronic liver fibrosis in mice respectively.
Huang B; Cheng X; Wang H; Huang W; la Ga Hu Z; Wang D; Zhang K; Zhang H; Xue Z; Da Y; Zhang N; Hu Y; Yao Z; Qiao L; Gao F; Zhang R
J Transl Med; 2016 Feb; 14():45. PubMed ID: 26861623
[TBL] [Abstract][Full Text] [Related]
9. Molecular and Cellular Functions Distinguish Superior Therapeutic Efficiency of Bone Marrow CD45 Cells Over Mesenchymal Stem Cells in Liver Cirrhosis.
Baligar P; Mukherjee S; Kochat V; Rastogi A; Mukhopadhyay A
Stem Cells; 2016 Jan; 34(1):135-47. PubMed ID: 26389810
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic effects of hepatocyte growth factor-overexpressing human umbilical cord blood-derived mesenchymal stem cells on liver fibrosis in rats.
Seo KW; Sohn SY; Bhang DH; Nam MJ; Lee HW; Youn HY
Cell Biol Int; 2014 Jan; 38(1):106-16. PubMed ID: 24115681
[TBL] [Abstract][Full Text] [Related]
11. Concise review: Therapeutic potential of mesenchymal stem cells for the treatment of acute liver failure and cirrhosis.
Volarevic V; Nurkovic J; Arsenijevic N; Stojkovic M
Stem Cells; 2014 Nov; 32(11):2818-23. PubMed ID: 25154380
[TBL] [Abstract][Full Text] [Related]
12. Mesenchymal stem cell therapy for cirrhosis: Present and future perspectives.
Eom YW; Kim G; Baik SK
World J Gastroenterol; 2015 Sep; 21(36):10253-61. PubMed ID: 26420953
[TBL] [Abstract][Full Text] [Related]
13. Use of mesenchymal stem cells to treat liver fibrosis: current situation and future prospects.
Berardis S; Dwisthi Sattwika P; Najimi M; Sokal EM
World J Gastroenterol; 2015 Jan; 21(3):742-58. PubMed ID: 25624709
[TBL] [Abstract][Full Text] [Related]
14. Liver Anti-Fibrosis Therapy with Mesenchymal Stem Cells Secreting Hepatocyte Growth Factor.
Ishikawa H; Jo J; Tabata Y
J Biomater Sci Polym Ed; 2012; 23(18):2259-72. PubMed ID: 22182291
[TBL] [Abstract][Full Text] [Related]
15. Liver-derived human mesenchymal stem cells: a novel therapeutic source for liver diseases.
Wang Y; Yu X; Chen E; Li L
Stem Cell Res Ther; 2016 May; 7(1):71. PubMed ID: 27176654
[TBL] [Abstract][Full Text] [Related]
16. Basic fibroblast growth factor-treated adipose tissue-derived mesenchymal stem cell infusion to ameliorate liver cirrhosis via paracrine hepatocyte growth factor.
Tang WP; Akahoshi T; Piao JS; Narahara S; Murata M; Kawano T; Hamano N; Ikeda T; Hashizume M
J Gastroenterol Hepatol; 2015 Jun; 30(6):1065-74. PubMed ID: 25639333
[TBL] [Abstract][Full Text] [Related]
17. The multiple functional roles of mesenchymal stem cells in participating in treating liver diseases.
Liu WH; Song FQ; Ren LN; Guo WQ; Wang T; Feng YX; Tang LJ; Li K
J Cell Mol Med; 2015 Mar; 19(3):511-20. PubMed ID: 25534251
[TBL] [Abstract][Full Text] [Related]
18. The therapeutic effects of bone marrow-derived mesenchymal stem cells and simvastatin in a rat model of liver fibrosis.
Motawi TM; Atta HM; Sadik NA; Azzam M
Cell Biochem Biophys; 2014 Jan; 68(1):111-25. PubMed ID: 23807535
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of bone marrow-derived mesenchymal stem cells on hepatic cirrhosis.
Dai LJ; Li HY; Guan LX; Ritchie G; Zhou JX
Stem Cell Res; 2009 Jan; 2(1):16-25. PubMed ID: 19383405
[TBL] [Abstract][Full Text] [Related]
20. Effect of bone marrow-derived mesenchymal stem cells on hepatic fibrosis in a thioacetamide-induced cirrhotic rat model.
Jang YO; Kim MY; Cho MY; Baik SK; Cho YZ; Kwon SO
BMC Gastroenterol; 2014 Nov; 14():198. PubMed ID: 25425284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
